World's Best Scientists 2026 revealed!
Pierre Bedossa

Pierre Bedossa

Award Badge
Medicine
France
2023

D-Index & Metrics

Medicine

D-Index
130
Citations
73534
World Ranking
2465
National Ranking
64

Pierre Bedossa publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Pierre Bedossa sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 771 publications — 86th percentile

86% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Pierre Bedossa D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Pierre Bedossa sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 130 D-Index — 88th percentile

88% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2023 - Research.com Medicine in France Leader Award

Overview

Pierre Bedossa is affiliated with Inserm in France and has contributed extensively to medical research, particularly in the field of hepatology. Their work spans a wide range of topics primarily related to liver disease, metabolism, and related diagnostic and treatment approaches.

Their research output includes a significant number of publications in leading scientific journals, with a strong focus on liver disease diagnosis and treatment. Among their recent notable papers are:

  • A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement (2020, Journal of Hepatology)
  • MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease (2020, Gastroenterology)
  • A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis (2024, New England Journal of Medicine)
  • NASH limits anti-tumour surveillance in immunotherapy-treated HCC (2021, Nature)
  • FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study (2020, The Lancet. Gastroenterology & Hepatology)

Their frequent coauthors highlight collaboration with key figures in hepatology and metabolic disease research, including:

  • Vlad Ratziu
  • Quentin M. Anstee
  • Stephen A. Harrison
  • Arun J. Sanyal
  • Jörn M. Schattenberg

Publication venues where Pierre Bedossa's work frequently appears include:

  • Journal of Hepatology
  • The Lancet. Gastroenterology & Hepatology
  • Digestive and Liver Disease
  • Gastroenterology
  • New England Journal of Medicine

Their research fields are focused within Medicine, with subfields emphasizing:

  • Epidemiology
  • Hepatology
  • Endocrinology, Diabetes and Metabolism
  • Molecular Biology
  • Cardiology and Cardiovascular Medicine

Major research topics cover various dimensions related to liver health and disease, including:

  • Liver Disease Diagnosis and Treatment
  • Liver Diseases and Immunity
  • Liver Disease and Transplantation
  • Diet, Metabolism, and Disease
  • Endoplasmic Reticulum Stress and Disease
  • Hepatitis C virus research
  • Pancreatitis Pathology and Treatment

Best Publications

  • An algorithm for the grading of activity in chronic hepatitis C

    Pierre Bedossa;Thierry Poynard

  • Natural history of liver fibrosis progression in patients with chronic hepatitis C

    Thierry Poynard;Pierre Bedossa;Pierre Opolon

  • Sampling variability of liver fibrosis in chronic hepatitis C.

    Pierre Bedossa;Delphine Dargère;Valerie Paradis

  • A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement.

    Mohammed Eslam;Philip N. Newsome;Shiv K. Sarin;Quentin M. Anstee

  • NASH limits anti-tumour surveillance in immunotherapy-treated HCC

    Dominik Pfister;Dominik Pfister;Nicolás Gonzalo Núñez;Roser Pinyol;Olivier Govaere

  • Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening

    Vlad Ratziu;Vlad Ratziu;Stephen A. Harrison;Sven Francque;Pierre Bedossa

  • Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease

    Peter J. Eddowes;Magali Sasso;Michael Allison;Emmanouil Tsochatzis

  • Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis

    Thomas Karlas;David Petroff;Magali Sasso;Jian Gao Fan

  • Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients

    Pierre Bedossa;Christine Poitou;Christine Poitou;Nicolas Veyrie;Jean-Luc Bouillot

  • Increased Infiltration of Macrophages in Omental Adipose Tissue Is Associated With Marked Hepatic Lesions in Morbid Human Obesity

    Raffaella Cancello;Joan Tordjman;Christine Poitou;Gaël Guilhem

  • Insulin Resistance in Chronic Hepatitis C: Association With Genotypes 1 and 4, Serum HCV RNA Level, and Liver Fibrosis

    Rami Moucari;Tarik Asselah;Dominique Cazals–Hatem;Hélène Voitot

  • Sources of variability in histological scoring of chronic viral hepatitis.

    Marie-Christine Rousselet;Sophie Michalak;Florence Dupré;Anne Croué

  • High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: a potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis.

    Valerie Paradis;Gabriel Perlemuter;Franck Bonvoust;Delphine Dargere

  • Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B

    Patrick Marcellin;Marianne Ziol;Pierre Bedossa;Catherine Douvin

  • Early serum HBsAg drop: a strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patients.

    Rami Moucari;Rami Moucari;Vincent Mackiewicz;Olivier Lada;Olivier Lada;Marie-Pierre Ripault;Marie-Pierre Ripault

  • Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease.

    Pierre Bedossa

  • A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. Multicenter Study Group.

    T Poynard;P Bedossa;M Chevallier;P Mathurin

  • Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: A pathological analysis

    Valérie Paradis;Stéphane Zalinski;Emna Chelbi;Nathalie Guedj

  • Fibrosis in human adipose tissue: composition, distribution, and link with lipid metabolism and fat mass loss.

    Adeline Divoux;Joan Tordjman;Danièle Lacasa;Nicolas Veyrie

  • A comparison of fibrosis progression in chronic liver diseases

    Thierry Poynard;Philippe Mathurin;Ching-Lung Lai;Dominique Guyader

Frequent Co-Authors

Valérie Paradis
Valérie Paradis Université Paris Cité
Thierry Poynard
Thierry Poynard Sorbonne University
Michel Vidaud
Michel Vidaud Université Paris Cité
Anne Couvelard
Anne Couvelard Université Paris Cité
Dominique Valla
Dominique Valla Université Paris Cité
Patrick Marcellin
Patrick Marcellin Université Paris Cité
Ivan Bièche
Ivan Bièche Institute Curie
Alain Sauvanet
Alain Sauvanet Université Paris Cité
Philippe Ruszniewski
Philippe Ruszniewski Université Paris Cité
Nathalie Boyer
Nathalie Boyer Université Paris Cité

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

As interest in studying Medicine in the USA grows, many students are exploring alternative and flexible online pathways into healthcare careers. One of the most popular options is advancing from registered nurse to bachelor’s degree. For those concerned about costs, you can find the cheapest rn to bsn program online to gain more qualifications without incurring heavy debt.

If you do not already have a nursing background, there are online direct entry msn programs designed for non-nurses, allowing career switchers to enter advanced nursing fields efficiently. Similarly, for those seeking nursing credentials quickly, many look for online adn programs for non nurses with more accessible admission standards.

Medicine-related roles extend beyond direct patient care. Medical billing and coding is a vital part of the healthcare system and can be completed 100% online. There are options for financial aid for medical billing and coding online classes, making this career accessible to many.

These flexible online options allow you to start or advance your healthcare career at your own pace and from anywhere in the USA.

Best Scientists Citing Pierre Bedossa

Trending Scientists

Recently Published Articles